Home
Login
Help
Search this site:
Registered Trials
By recruitment status
By sponsor
By registration date
Advanced search for trials
Registration process
To register a trial
Sponsor registration form
RPCEC trial registration Data Set
To update a registered trial
To disclosure the results of registered trial
Home
|
By sponsor
CENTER OF MOLECULAR IMMUNOLOGY(CIM).CIMAB
Trials shown by sponsor
Public title
Date of Registration
State
ior ®EPOCIM as a cardioprotective agent in the surgery of rheumatic valvular disease.
26/08/2013
Registered outdated
NeuroEPO in healthy volunteers.
2013-06-10
Registered
ior EPOCIM ® in the management of anemia of the preterm infant.Phase IV.
2013-02-26
Registered
Nimotuzumab in tumors of head and neck .Phase IV
2013-02-01
Registered
Nimotuzumab for the treatment of high grade of malignancy tumors
2013-02-01
Registered
iorEPOCIM-Stroke-Phase I
2012-09-17
Registered outdated
Effectiveness and safety of ior®EPOCIM in Chronic Kidney Disease patients in pre-dialysis.
2011-11-11
Registered
Effect and Safety of ior® EPOCIM in patients with Non-Hodking Lymphoma treated with anthracyclines.
2010-06-11
Registered
EPOCIM in benign prostatic hyperplasia.
2009-10-23
Registered
Effectiveness and safety of ior EPOCIM in anemia in premature infant.
2009-10-22
Registered
Nimotuzumab- Head and neck cancer
2009-10-22
Registered
Effectiveness and Safety of Nimotuzumab for the treatment of patients with glioma tumors
2009-09-18
Registered
Effectiveness and Safety of use ior LeukoCIM as prophylaxis and treatment of Neutropenia in patients with HIV / AIDS.
2009-08-20
Registered
Safety assessment of Granulocyte Colony Stimulating Factor:ior LeukoCIM in oncohematologic patients.Phase IV study.
2009-07-24
Registered
Impact of the Granulocytes Colony-Stimulating Factor (ior-LeukoCIM) in primary and secondary prophylaxis and post chemotherapy and/or radiotherapy neutropenia in oncohematological pediatric patients.
2009-07-24
Registered
Effectiveness and Safety of ior EPOCIM in patients with Chronic Renal Failure on dialysis methods.
2009-07-10
Registered
Therapeutic Equivalence between ior EPOCIM and EPO without albumin, for patients with Chronic Renal failure on Peritoneal dialysis methods.(Hemodialysis or peritoneal dialysis).
2009-07-03
Registered
Safety evaluation of Recombinant Human Erythropoietin ior EPOCIM in the treatment of patient with cerebral infarction acute. Study Stage I.
2009-07-03
Registered outdated
Impact of Human Recombinant Erithoropoietin (ior EPOCIM) in cancer patients with post Chemo and Radiotherapy induced anemia.
2009-07-03
Registered
Impact of Recombinant Human Erythropoietin (ior EPO-CIM) in oncology pediatric patients with post chemo and /or radiotherapy.
2009-07-03
Registered
1
2
next ›
last »
About the RPCEC
Structure and governance
Policy
Publications
Awards
Communications
News
Useful resources
Fundamentals of the registry
References of clinical trials
Cuban regulations
Other registries
International Clinical Trials Registry Platform